New Results
A discrete event simulation to evaluate the cost effectiveness of germline BRCA1 and BRCA2 testing in UK women with ovarian cancer
Anthony Eccleston, Anthony Bentley, Matthew Dyer, Ann Strydom, Wim Vereecken, Angela George, View ORCID ProfileNazneen Rahman
doi: https://doi.org/10.1101/060418
Anthony Eccleston
1DRG Abacus, Bicester, Oxfordshire, UK.;
Anthony Bentley
1DRG Abacus, Bicester, Oxfordshire, UK.;
Matthew Dyer
3AstraZeneca UK Ltd, Luton, UK;
Ann Strydom
2Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK;
Wim Vereecken
3AstraZeneca UK Ltd, Luton, UK;
Angela George
2Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK;
4Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, UK
Nazneen Rahman
2Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK;
4Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, UK
Article usage
Posted June 24, 2016.
A discrete event simulation to evaluate the cost effectiveness of germline BRCA1 and BRCA2 testing in UK women with ovarian cancer
Anthony Eccleston, Anthony Bentley, Matthew Dyer, Ann Strydom, Wim Vereecken, Angela George, Nazneen Rahman
bioRxiv 060418; doi: https://doi.org/10.1101/060418
Subject Area
Subject Areas
- Biochemistry (11574)
- Bioengineering (8626)
- Bioinformatics (28876)
- Biophysics (14809)
- Cancer Biology (11945)
- Cell Biology (17175)
- Clinical Trials (138)
- Developmental Biology (9309)
- Ecology (14023)
- Epidemiology (2067)
- Evolutionary Biology (18130)
- Genetics (12148)
- Genomics (16621)
- Immunology (11712)
- Microbiology (27705)
- Molecular Biology (11402)
- Neuroscience (60109)
- Paleontology (448)
- Pathology (1849)
- Pharmacology and Toxicology (3185)
- Physiology (4878)
- Plant Biology (10279)
- Synthetic Biology (2850)
- Systems Biology (7291)
- Zoology (1619)